benzyloxyresorufin has been researched along with 7-ethoxy-4-trifluoromethylcoumarin in 2 studies
Studies (benzyloxyresorufin) | Trials (benzyloxyresorufin) | Recent Studies (post-2010) (benzyloxyresorufin) | Studies (7-ethoxy-4-trifluoromethylcoumarin) | Trials (7-ethoxy-4-trifluoromethylcoumarin) | Recent Studies (post-2010) (7-ethoxy-4-trifluoromethylcoumarin) |
---|---|---|---|---|---|
20 | 0 | 2 | 37 | 0 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halpert, JR; Li, W; Liu, H; Qun He, Y; Scott, EE | 1 |
Chen, CS; Halpert, JR; Kumar, S; Liu, H; Sun, L; Waxman, DJ | 1 |
2 other study(ies) available for benzyloxyresorufin and 7-ethoxy-4-trifluoromethylcoumarin
Article | Year |
---|---|
Mutagenesis and molecular dynamics suggest structural and functional roles for residues in the N-terminal portion of the cytochrome P450 2B1 I helix.
Topics: Amino Acid Substitution; Benzphetamine; Computer Simulation; Coumarins; Cytochrome P-450 CYP2B1; DNA Primers; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Oxazines; Protein Binding; Protein Structure, Secondary; Recombinant Proteins; Testosterone | 2004 |
Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents, Alkylating; Aryl Hydrocarbon Hydroxylases; Coumarins; Cyclophosphamide; Directed Molecular Evolution; Hydroxylation; Ifosfamide; Liver; Models, Molecular; Mutagenesis, Site-Directed; Oxazines; Oxidation-Reduction; Prodrugs; Rats; Testosterone | 2007 |